Adjuvant chemotherapy with gemcitabine plus erlotinib vs. gemcitabine alone for patients with resected pancreatic ductal adenocarcinoma: is there a role for erlotinib?-review of the open label phase III trial CONKO 005

被引：0

作者：

Wisniewski, Mathilde ^{[1
]}

Placide, Pierre-Alain ^{[1
]}

Granier, Sandra ^{[1
]}

Al Shatti, Yacoub ^{[1
]}

Al Qalaf, Shuaib ^{[1
]}

Bouattour, Mohamed ^{[1
]}

Lamuraglia, Michele ^{[1
]}

Hammel, Pascal ^{[1
]}

机构：

[1] Univ Denis Diderot Paris VII, AP HP, Hop Beaujon, Dept Digest & Med Oncol, Clichy, France

来源：

HEPATOBILIARY SURGERY AND NUTRITION | 2018年 / 7卷 / 05期

关键词：

RANDOMIZED CONTROLLED-TRIAL; CANCER; CHEMORADIOTHERAPY; MULTICENTER;

D O I：

10.21037/hbsn.2018.08.03

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：399 / 402

页数：4

共 17 条

[1] Unicancer GI PRODIGE 24/CCTG PA.6 trial: A multicenter international randomized phase III trial of adjuvant mFOLFIRINOX versus gemcitabine (gem) in patients with resected pancreatic ductal adenocarcinomas.
Conroy, Thierry
Hammel, Pascal
Hebbar, Mohamed
Ben Abdelghani, Meher
Wei, Alice Chia-chi
Raoul, Jean-Luc
Chone, Laurence
Francois, Eric
Artru, Pascal
Biagi, James Joseph
Lecomte, Thierry
Assenat, Eric
Faroux, Roger
Ychou, Marc
Volet, Julien
Sauvanet, Alain
Jouffroy-Zeller, Claire
Rat, Patrick
Castan, Florence
Bachet, Jean-Baptiste
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (18)
[2] Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial
Greenhalf, William
Ghaneh, Paula
Neoptolemos, John P.
Palmer, Daniel H.
Cox, Trevor F.
Lamb, Richard F.
Garner, Elizabeth
Campbell, Fiona
Mackey, John R.
Costello, Eithne
Moore, Malcolm J.
Valle, Juan W.
McDonald, Alexander C.
Carter, Ross
Tebbutt, Niall C.
Goldstein, David
Shannon, Jennifer
Dervenis, Christos
Glimelius, Bengt
Deakin, Mark
Charnley, Richard M.
Lacaine, Francois
Scarfe, Andrew G.
Middleton, Mark R.
Anthoney, Alan
Halloran, Christopher M.
Mayerle, Julia
Olah, Attila
Jackson, Richard
Rawcliffe, Charlotte L.
Scarpa, Aldo
Bassi, Claudio
Buechler, Markus W.
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (01):
[3] Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib The LAP07 Randomized Clinical Trial
Hammel, Pascal
Huguet, Florence
van Laethem, Jean-Luc
Goldstein, David
Glimelius, Bengt
Artru, Pascal
Borbath, Ivan
Bouche, Olivier
Shannon, Jenny
Andre, Thierry
Mineur, Laurent
Chibaudel, Benoist
Bonnetain, Franck
Louvet, Christophe
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (17): : 1844 - 1853
[4] Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Moore, Malcolm J.
Goldstein, David
Hamm, John
Figer, Arie
Hecht, Joel R.
Gallinger, Steven
Au, Heather J.
Murawa, Pawel
Walde, David
Wolff, Robert A.
Campos, Daniel
Lim, Robert
Ding, Keyue
Clark, Gary
Voskoglou-Nomikos, Theodora
Ptasynski, Mieke
Parulekar, Wendy
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 1960 - 1966
[5] Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
Neoptolemos, John P.
Palmer, Daniel H.
Ghaneh, Paula
Psarelli, Eftychia E.
Valle, Juan W.
Halloran, Christopher M.
Faluyi, Olusola
O'Reilly, Derek A.
Cunningham, David
Wadsley, Jonathan
Darby, Suzanne
Meyer, Tim
Gillmore, Roopinder
Anthoney, Alan
Lind, Pehr
Glimelius, Bengt
Falk, Stephen
Izbicki, Jakob R.
Middleton, Gary William
Cummins, Sebastian
Ross, Paul J.
Wasan, Harpreet
McDonald, Alec
Crosby, Tom
Ma, Yuk Ting
Patel, Kinnari
Sherriff, David
Soomal, Rubin
Borg, David
Sothi, Sharmila
Hammel, Pascal
Hackert, Thilo
Jackson, Richard
Buechler, Markus W.
[J]. LANCET, 2017, 389 (10073) : 1011 - 1024
[6] Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
Neoptolemos, John P.
Stocken, Deborah D.
Bassi, Claudio
Ghaneh, Paula
Cunningham, David
Goldstein, David
Padbury, Robert
Moore, Malcolm J.
Gallinger, Steven
Mariette, Christophe
Wente, Moritz N.
Izbicki, Jakob R.
Friess, Helmut
Lerch, Markus M.
Dervenis, Christos
Olah, Attila
Butturini, Giovanni
Doi, Ryuichiro
Lind, Pehr A.
Smith, David
Valle, Juan W.
Palmer, Daniel H.
Buckels, John A.
Thompson, Joyce
McKay, Colin J.
Rawcliffe, Charlotte L.
Buechler, Markus W.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (10): : 1073 - 1081
[7] Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer:: a randomised controlled trial
Neoptolemos, JP
Dunn, JA
Stocken, DD
Almond, J
Link, K
Beger, H
Bassi, C
Falconi, M
Pederzoli, P
Dervenis, C
Fernandez-Cruz, L
Lacaine, F
Pap, A
Spooner, D
Kerr, DJ
Friess, H
Büchler, MW
[J]. LANCET, 2001, 358 (9293) : 1576 - 1585
[8] A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
Neoptolemos, JP
Stocken, DD
Friess, H
Bassi, C
Dunn, JA
Hickey, H
Beger, H
Fernandez-Cruz, L
Dervenis, C
Lacaine, F
Falconi, M
Pederzoli, P
Pap, A
Spooner, D
Kerr, DJ
Büchler, MW
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) : 1200 - 1210
[9] Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer The CONKO-001 Randomized Trial
Oettle, Helmut
Neuhaus, Peter
Hochhaus, Andreas
Hartmann, Joerg Thomas
Gellert, Klaus
Ridwelski, Karsten
Niedergethmann, Marco
Zuelke, Carl
Fahlke, Joerg
Arning, Michael B.
Sinn, Marianne
Hinke, Axel
Riess, Hanno
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (14): : 1473 - 1481
[10] Ryan DP, 2014, NEW ENGL J MED, V371, P2140, DOI 10.1056/NEJMc1412266

← 1 2 →